Short answer
Inhibikase Therapeutics, Inc. (IKT) filed an 8-K current report with the SEC on October 20, 2026 reporting Item 5.02 (Departure/Election of Directors or Officers), Item 7.01 (Regulation FD Disclosure), Item EX-99.1 (Exhibit EX-99.1). Dennis Berman resigned as director and Compensation Committee Chair on October 19, 2026.
Inhibikase Therapeutics, Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 5.02 · Departure/Election of Directors or Officers
- Dennis Berman resigned as director and Compensation Committee Chair on October 19, 2026
- Scott Wasserman appointed independent Class III director through 2029 annual meeting
- Wasserman joins Compensation Committee, preserving committee coverage after Berman’s departure
- 310,000 non-qualified stock options plus cash director compensation, creating shareholder dilution potential
- No disclosed disagreements, related-party transactions, or selection arrangements involving Wasserman
Item 7.01 · Regulation FD Disclosure
- Scott Wasserman appointed to Inhibikase Therapeutics’ board of directors
- Board appointment may influence governance, strategic oversight and shareholder confidence
- Press release dated October 20, 2026, provides the substantive appointment details
Item EX-99.1 · Exhibit EX-99.1
- Scott Wasserman appointed director effective October 19, 2026, replacing departing director Dennis Berman
- Experienced cardiovascular and metabolic drug developer, including leadership of Repatha, Evenity and Aimovig programs
- Appointment strengthens board expertise for global Phase 3 IMPROVE-PAH study of once-daily IKT-001
- IMPROVE-PAH actively enrolling across approximately 180 sites worldwide
- Clinical and regulatory execution remain key risks, with no change to IKT-001’s development status disclosed
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Inhibikase Therapeutics, Inc. 8-K filings
Get the next IKT 8-K as it lands
Follow IKT for push alerts, or ask the research agent what this filing means.